< Terug naar vorige pagina

Onderzoeker

Thomas Ertveldt

  • Onderzoeksdoeleinden:

    Currently, i'm employed as a PhD-Candidate at the "Laboratory for Molecular and Cellular Therapy" (LMCT) researchgroup at the Vrije Universiteit Brussel. My work entails a jointproject between the LMCT and the "in Vivo Cellular and Molecular Imaging" (ICMI) researchgroups in which I’m investigating the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s).

  • Trefwoorden:Geneeskunde
  • Disciplines:Kankertherapie, Bestralingstherapie, Adaptieve immunologie, Toegepaste immunologie, Nucleaire beeldvorming
  • Gebruikers van onderzoeksexpertise:

    Currently, i'm employed as a PhD-Candidate at the "Laboratory for Molecular and Cellular Therapy" (LMCT) researchgroup at the Vrije Universiteit Brussel. My work entails a jointproject between the LMCT and the "in Vivo Cellular and Molecular Imaging" (ICMI) researchgroups in which I’m investigating the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s).